CERASORB DENTAL

FDA Premarket Approval P800035 S011

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for design changes, a trade name change, and new manufacturing sites. This approval also acknowledges that ownership has been transferred from miter, inc. To curasan ag. Cerasorb dental will be manufactured at two new facilities located at curasan ag, germany and willy rusch ag, germany. The device, as modified, will be marketed under the trade name cerasorb dental and is indicated for defects after extirpation of dental alveolar cysts; repair of marginal and periapical periodontal alveolar bony pockets as well as bifurcations and trifurcations of the teeth; augmentation of the atrophied alveolar ridge; alveolar augmentation of mandibular and maxillary ridges; defects after apicoectomy; and filling bone defects after surgical resection of impacted teeth (without implantation).

DeviceCERASORB DENTAL
Generic NameBone Grafting Material, For Dental Bone Repair
ApplicantCURASAN AG
Date Received2002-04-05
Decision Date2003-12-08
PMAP800035
SupplementS011
Product CodeLPK 
Advisory CommitteeDental
Supplement TypeNormal 180 Day Track
Supplement ReasonChange Design/components/specifications/material
Expedited ReviewNo
Combination Product No
Applicant Address CURASAN AG lindigstrasse 4 kleinostheim D-638-6380

Supplemental Filings

Supplement NumberDateSupplement Type
P800035Original Filing
S011 2002-04-05 Normal 180 Day Track
S010 2001-06-25 Normal 180 Day Track
S009
S008 1983-10-11
S007 1983-09-13
S006
S005 1982-06-15
S004 1982-12-20
S003 1982-10-22
S002 1982-06-30
S001 1981-12-14

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.